The APAC region is a hub for large, multi-center Phase II and Phase III trials, where timelines, patient diversity, and regulatory navigation are critical. Our success here is built on
By combining global oversight with local agility, DiagnoSearch ensures that sponsors can confidently advance development programs in Southeast Asia and beyond.

DiagnoSearch began operations in India in 1995 as a one of the first central laboratories dedicated to clinical trials in India. Responding to Industry demand for clinical research services, DiagnoSearch evolved to become one of the first home grown CROs in the country.
For the past 30+ years, we have served 65+ clients across all functional areas and most therapeutic areas and phases, leveraging our Indian operations.
What we bring to India

Pioneering High-Volume Vaccine Trials
In Bangladesh, DiagnoSearch is one of the few CROs with in-country site monitors, ensuring continuous oversight and reliable execution. Our partnerships with leading institutes have enabled the enrollment of thousands of participants in high-volume vaccine trials.
Our Bangladesh portfolio includes pivotal Phase III vaccine studies, such as the Oral Polio Vaccine and Hexavalent Vaccine trials. In this region, where preventive medicine and vaccine development are at the forefront, our expertise ensures successful trial delivery through
Bangladesh is an emerging center for vaccine research, and DiagnoSearch continues to play a pioneering role in shaping its clinical research ecosystem.

DiagnoSearch began supporting clinical trials in Australia in 2015 and in New Zealand in 2025, thereby expanding our footprint in APAC
A brief timeline of our operations
What we bring to Australia & New Zealand